Report Categories
View AllRecent Articles
View All
Gilead Sciences GILD Pipeline Milestones and Arcellx Acquisition Reinforce LongTerm Growth Trajectory in HIV and Oncology
SRTAW Strata outlines new critical medical service expansion plans alongside its latest quarterly earnings release
Equity Residential REET Wall Street Consensus Recent Performance and Forward Outlook for the US Multifamily REIT
KYTX Kyverna Therapeutics posts narrower Q4 2025 loss than expected shares rise 08 percent in todays trading